Quantcast
Connect with us

EpiPen maker Mylan faces anti-trust investigation following massive price increase

Published

on

The maker of the Epipen, used for the emergency treatment of anaphylactic shock, is facing a federal anti-trust investigation after lawmakers were alerted to a massive price increase last year.

According to the Washington Post, Mylan, the maker of the injectable drug, admitted that the Federal Trade Commission requested information from them months ago “as part of a preliminary investigation.”

ADVERTISEMENT

Mylan has been under scrutiny after raising the price of the EpiPen more than 500 percent in recent years, to over $600 per two-pack.

Adding fuel to the fire was the fact that Mylan’s CEO, Heather Bresch, is the daughter of Democratic West Virginia Sen. Joe Manchin. Bresch helped engineer the bump in prices after taking over as head of the company.

At issue now are accusation that Mylan may have tried to halt competition while reaping huge profits.

Mylan is already under scrutiny by New York Attorney General Eric Schneiderman, who opened an investigation into their business practices last September, accusing the company of inserting “potentially anticompetitive terms” into its sales contracts for Epipen “with numerous local school systems.”

ADVERTISEMENT

By law, those schools must keep EpiPens on hand for the protection of children.

A spokesperson for Mylan dismissed the accusations of illegal actions, calling them “without merit.”

“Any suggestion that Mylan took any inappropriate or unlawful actions to prevent generic competition is without merit,” spokesperson Nina Devlin said in a statement. “”We note that the epinephrine auto-injector market is and always has been competitive, with multiple products competing on the market since we acquired EpiPen Auto-Injector.”

ADVERTISEMENT

Devlin added, “Further, Teva has had patent licenses to launch their proposed generic alternative to EpiPen Auto-Injector since June 2015, pending FDA approval, years prior to patent expiry.”

In October, Mylan agreed to pay a $465 million settlement, without an admission of wrongdoing, with the Justice Department over claims the company over-billed Medicaid by misclassifying the EpiPen in order to take advantage of a federal drug rebate program.

Enjoy this piece?

… then let us make a small request. Like you, we here at Raw Story believe in the power of progressive journalism — and we’re investing in investigative reporting as other publications give it the ax. Raw Story readers power David Cay Johnston’s DCReport, which we've expanded to keep watch in Washington. We’ve exposed billionaire tax evasion and uncovered White House efforts to poison our water. We’ve revealed financial scams that prey on veterans, and legal efforts to harm workers exploited by abusive bosses. We’ve launched a weekly podcast, “We’ve Got Issues,” focused on issues, not tweets. And unlike other news outlets, we’ve decided to make our original content free. But we need your support to do what we do.

Raw Story is independent. You won’t find mainstream media bias here. We’re not part of a conglomerate, or a project of venture capital bros. From unflinching coverage of racism, to revealing efforts to erode our rights, Raw Story will continue to expose hypocrisy and harm. Unhinged from billionaires and corporate overlords, we fight to ensure no one is forgotten.

We need your support to keep producing quality journalism and deepen our investigative reporting. Every reader contribution, whatever the amount, makes a tremendous difference. Invest with us in the future. Make a one-time contribution to Raw Story Investigates, or click here to become a subscriber. Thank you. Click to donate by check.

Enjoy this piece?

… then let us make a small request. Like you, we here at Raw Story believe in the power of progressive journalism — and we’re investing in investigative reporting as other publications give it the ax. Raw Story readers power David Cay Johnston’s DCReport, which we've expanded to keep watch in Washington. We’ve exposed billionaire tax evasion and uncovered White House efforts to poison our water. We’ve revealed financial scams that prey on veterans, and efforts to harm workers exploited by abusive bosses. We’ve launched a weekly podcast, “We’ve Got Issues,” focused on issues, not tweets. Unlike other news sites, we’ve decided to make our original content free. But we need your support to do what we do.

Raw Story is independent. You won’t find mainstream media bias here. We’re not part of a conglomerate, or a project of venture capital bros. From unflinching coverage of racism, to revealing efforts to erode our rights, Raw Story will continue to expose hypocrisy and harm. Unhinged from corporate overlords, we fight to ensure no one is forgotten.

We need your support to keep producing quality journalism and deepen our investigative reporting. Every reader contribution, whatever the amount, makes a tremendous difference. Invest with us in the future. Make a one-time contribution to Raw Story Investigates, or click here to become a subscriber. Thank you.



Report typos and corrections to: [email protected]. Send news tips to: [email protected].
READ COMMENTS - JOIN THE DISCUSSION
Continue Reading

Breaking Banner

Trump is ‘having a full-blown mental breakdown’ and needs to resign: Ex-Trump staffer

Published

on

Leading Republican elected officials should work with President Donald Trump's family to negotiate him resigning from office, a former top White House official suggested on MSNBC on Friday.

Former White House press secretary Anthony Scaramucci blasted his former boss during an interview with Chuck Todd on MSNBC's "Meet the Press Daily."

"He has totally and completely lost it. There is nobody that can look at the situation, read the tweets, look at the press sprays, and say he hasn’t lost it," Scaramucci argued.

"What does that mean, lost it?" Todd asked. "Define that."

Continue Reading

Breaking Banner

Trump responds to China raising tariffs — by raising tariffs on over half a trillion dollars in Chinese goods

Published

on

After US markets tanked on Friday, President Donald Trump dramatically escalated his trade war with China.

"For many years China (and many other countries) has been taking advantage of the United States on trade, intellectual property theft, and much more. Our country has been losing hundreds of billions of dollars a year to China, with no end in sight," Trump tweeted.

"Sadly, past Administrations have allowed China to get so far ahead of fair and balanced trade that it has become a great burden to the American taxpayer. As President, I can no longer allow this to happen," he argued.

Continue Reading
 

Breaking Banner

MSNBC anchor blasts Trump’s ‘lunacy’ after ‘a Twitter tirade that sent the Dow spiraling’

Published

on

The New York Stock Exchange closed down over 600 points on Friday as President Donald Trump's trade war with China escalated.

MSNBC anchor John Heilemann said, "we’re hours away for the president taking off to the G7 summit in Bairritz, France, where allies are bracing for the Trump-fueled mayhem that is now 100% certain to ensue, with Trump like a drunken traveler in the departure lounge about to take a trip that he dreads, already sewing global chaos, days-long public meltdown typically moved from words to actions."

"Donald Trump beginning this day with a Twitter tirade that sent the Dow spiraling, closing down more than 600 points today and escalating his trade war with China with these norm-shattering, power-abusing words in this tweet," he said, putting the tweet on-screen.

Continue Reading
 
 

Thank you for whitelisting Raw Story!

As a special thank you, from now until August 31st, we're offering you a discounted rate of $5.99/month to subscribe and get ad-free access. We're honored to have you as a reader. Thank you. :) —Elias, Membership Coordinator
LEARN MORE
close-link
close-image